Navigating EU Joint Clinical Assessments & Joint Scientific Consultations from January 2025 Onward

Emma Hawe, MSc
Head, Data Analytics and Design Strategy
Emma begins by discussing what drug manufacturers in the EU need to know about joint clinical assessment, and how time pressures within the guidelines may affect their development. She then shares her knowledge about how companies are responding to expected challenges with joint clinical assessments and lastly touches on joint scientific consultations.
www.rtihs.org/...
00:09:04 What do we need to know about Joint Clinical Assessments (JCAs)?
2:23:17 Additional time pressure for the manufacturers
04:45:05 How are companies responding to expected challenges with joint clinical assessments, and what is RTI Health Solutions doing to support them?
06:34:14 Joint Scientific Consultations